UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response

Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.1011-1016

2008

Volltextzugriff (PDF)

B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell‐activating factor‐binding receptors on B cell subsets

Clinical and experimental immunology, 2017-12, Vol.190 (3), p.372-383

2017

Volltextzugriff (PDF)

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients

Rheumatology (Oxford, England), 2005-12, Vol.44 (12), p.1542-1545

2005

Volltextzugriff (PDF)

Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross‐sectional study

Clinical and experimental immunology, 2016-05, Vol.184 (2), p.237-247

2016

Volltextzugriff (PDF)

Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs

Rheumatology (Oxford, England), 2007-04, Vol.46 (4), p.626-630

2007

Volltextzugriff (PDF)

The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment

Journal of autoimmunity, 2014-05, Vol.50, p.67-76

2014

Volltextzugriff (PDF)

AB0372 Treatment To Target Following Initiation of Treatment with Rituximab in Rheumatoid Arthritis: Real Life Experience

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1031-1031

2016

Volltextzugriff (PDF)

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

Annals of the rheumatic diseases, 2002-10, Vol.61 (10), p.883-888

2002

Volltextzugriff (PDF)

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

Rheumatology (Oxford, England), 2001-02, Vol.40 (2), p.205-211

2001

Volltextzugriff (PDF)

OP0159 Improving B-Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Resistance To Rituximab and The Potential of Obinutuzumab

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.116-116

2016

Volltextzugriff (PDF)

Prospects for B-cell-targeted therapy in autoimmune disease

Rheumatology (Oxford, England), 2005-02, Vol.44 (2), p.151-156

2005

Volltextzugriff (PDF)

FRI0228 Safety and efficacy of rituximab in patients with rheumatoid arthritis and lung involvement

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A450-A450

2013

Volltextzugriff (PDF)

FRI0395 Effect of Rituximab on Different Isotypes of Serum Immunoglobulins in Patients with Sle

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.530-530

2014

Volltextzugriff (PDF)

FRI0396 Type2 Anti-CD20 Antibodies do not Rapidly Internalise from the Surface of B Cells from Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus and Lyse Them More Efficiently than Rituximab (Type 1 Anti-20Antibody)

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.530-530

2014

Volltextzugriff (PDF)

Effect of rituximab on B cell phenotype and serum B cell‐activating factor levels in patients with thrombotic thrombocytopenic purpura

Clinical and experimental immunology, 2015-03, Vol.179 (3), p.414-425

2015

Volltextzugriff (PDF)

AB0499 Changes in the Relationship between Baff, BAFF-R and B Cell Phenotype following Treatment with Rituximab in Patients with Systemic Lupus Erythematosus

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.972-972

2014

Volltextzugriff (PDF)

OP0318 Use of an in Vitro Whole Blood Depletion Assay to Compare the Efficacy of B Cell Depleting Agents in Patients with Systemic Lupus Erythematosus

Annals of the rheumatic diseases, 2013-06, Vol.72 (Suppl 3), p.A162-A162

2013

Volltextzugriff (PDF)

THU0497 Re-Introduction of TNF Blockade during Partial Response to Anti-CD20 Therapy in Patients with RA: Can we Achieve Clinical Remission?

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.355-355

2014

Volltextzugriff (PDF)

AB0201 Investigation of BAFF/BLYS–binding receptors (BBR) on B cells from patients with systemic lupus erythematosus (SLE)

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.649-649

2013

Volltextzugriff (PDF)

Repeated B cell depletion in treatment of refractory systemic lupus erythematosus

Annals of the rheumatic diseases, 2006-07, Vol.65 (7), p.942-945

2006

Volltextzugriff (PDF)

SAT0179 Serum rituximab levels and efficiency of B-cell depletion: Differences between patients with systemic lupus erythematosus and rheumatoid arthritis

Annals of the rheumatic diseases, 2013-06, Vol.71 (Suppl 3), p.532-532

2013

Volltextzugriff (PDF)

Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy

Clinical and experimental rheumatology, 2008-09, Vol.26 (5), p.887

2008

Volltextzugriff (PDF)

AB0085 Serum Levels of CXCL13 Are Increased in Untreated Patients with Rheumatoid Arthritis from the First Weeks of Disease Development

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.832-832

2014

Volltextzugriff (PDF)

B cell depletion therapy in rheumatic disease

Best practice & research. Clinical rheumatology, 2006-10, Vol.20 (5), p.915-928

2006

Volltextzugriff (PDF)

Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy

Rheumatology (Oxford, England), 2007-01, Vol.46 (1), p.29-36

2007

Volltextzugriff (PDF)

1 – 25 von 3.690

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.600)
Mit Volltextzugriff
(3.214)

Publikationsform

6 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(2.204)
Physical Sciences
(1.592)
Physics
(1.206)
Physics Of Elementary Particles And Fields
(464)
Astronomy & Astrophysics
(417)
Life Sciences & Biomedicine
(413)
Technology
(356)
Mathematics
(330)
Physics, Multidisciplinary
(326)
Chemistry
(292)
Classical And Quantum Mechanics, General Physics
(281)
Exact Sciences And Technology
(277)
Materials Science
(232)
Physics, Applied
(228)
Science & Technology - Other Topics
(227)
Interactions
(196)
Physics, Particles & Fields
(196)
Biological And Medical Sciences
(192)
Spectra
(188)
Humans
(179)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)

Menü

Weitere Dienste

Einstellungen

B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response

B cell phenotypes in patients with rheumatoid arthritis relapsing after rituximab: expression of B cell‐activating factor‐binding receptors on B cell subsets

B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients

Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross‐sectional study

Repeated B lymphocyte depletion with rituximab in rheumatoid arthritis over 7 yrs

The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment

AB0372 Treatment To Target Following Initiation of Treatment with Rituximab in Rheumatoid Arthritis: Real Life Experience

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

OP0159 Improving B-Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Resistance To Rituximab and The Potential of Obinutuzumab

Prospects for B-cell-targeted therapy in autoimmune disease

FRI0228 Safety and efficacy of rituximab in patients with rheumatoid arthritis and lung involvement

FRI0395 Effect of Rituximab on Different Isotypes of Serum Immunoglobulins in Patients with Sle

FRI0396 Type2 Anti-CD20 Antibodies do not Rapidly Internalise from the Surface of B Cells from Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus and Lyse Them More Efficiently than Rituximab (Type 1 Anti-20Antibody)

Effect of rituximab on B cell phenotype and serum B cell‐activating factor levels in patients with thrombotic thrombocytopenic purpura

AB0499 Changes in the Relationship between Baff, BAFF-R and B Cell Phenotype following Treatment with Rituximab in Patients with Systemic Lupus Erythematosus

OP0318 Use of an in Vitro Whole Blood Depletion Assay to Compare the Efficacy of B Cell Depleting Agents in Patients with Systemic Lupus Erythematosus

THU0497 Re-Introduction of TNF Blockade during Partial Response to Anti-CD20 Therapy in Patients with RA: Can we Achieve Clinical Remission?

AB0201 Investigation of BAFF/BLYS–binding receptors (BBR) on B cells from patients with systemic lupus erythematosus (SLE)

Repeated B cell depletion in treatment of refractory systemic lupus erythematosus

SAT0179 Serum rituximab levels and efficiency of B-cell depletion: Differences between patients with systemic lupus erythematosus and rheumatoid arthritis

Clinical outcome following B cell depletion therapy in eight patients with refractory idiopathic inflammatory myopathy

AB0085 Serum Levels of CXCL13 Are Increased in Untreated Patients with Rheumatoid Arthritis from the First Weeks of Disease Development

B cell depletion therapy in rheumatic disease

Bone marrow B-lineage cells in patients with rheumatoid arthritis following rituximab therapy

Suchergebnisse filtern